MP-424 (generic name:Telaprevir)

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Chronic Hepatitis C

Phase 3

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients

CompletedNCT01466192

Tanabe Pharma CorporationChronic Hepatitis C

Start: 2012-05-31End: 2013-08-31Updated: 2026-01-06

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients

CompletedNCT01468584

Tanabe Pharma CorporationChronic Hepatitis C

Start: 2011-11-30End: 2013-09-30Updated: 2026-01-06